About: Impact of COVID-19 on thyroid cancer surgery and adjunct therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of COVID-19 on thyroid cancer surgery and adjunct therapy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Impact of COVID-19 on thyroid cancer surgery and adjunct therapy
Creator	Al-Omar, Khaled Bakkar, Sohail Miccoli, Paolo Al-Dabbas, Nesrin Aljarrah, · Moh'd Al-Dabbas, · Samara, Samara
topic	covid:9eb633f8b4fa78eeaed05c1d39ce812b424cae6c#this
source	Medline; PMC
abstract	COVID-19 has profoundly modified the way healthcare is delivered. Jordan imposed lockdown and restrictive policies between March 17 and May 20, 2020. We aimed to assess the impact of such measures on thyroid cancer treatment plans. In the specified period, 12 patients were scheduled for surgery. Since papillary carcinoma was the preoperative diagnosis in all cases, radioactive iodine ablation (RIA) therapy was also planned 3–4 weeks following surgery after withdrawing thyroxine and achieving a thyroid stimulating hormone (TSH) level > 30 mU/L. Thyroxine withdrawal is the routine method applied for RIA in Jordan as it is less costly compared to the rapid method of exogenous stimulation using recombinant TSH. All surgical procedures were performed without delay since all patients were asymptomatic per flu-like illness and came from a region of low COVID-19 prevalence. These included total thyroidectomy (n = 11), bilateral therapeutic central compartment neck dissection (n = 7), lateral compartment neck dissection (n = 5). However, the RIA treatment plan was altered considerably according to the period in which they were operated. 6 out of the 7 patients operated in March changed to the stimulated method of RIA at a considerable additional extra cost. The seventh patient and the April patient opt to delay RIA until after lockdown. The remaining cases (operated in May) followed the usual withdrawal method as restrictions were due to an end. The restrictive measures applied during COVID-19 did not affect the safe and timely delivery of surgical care. However, it added a financial and psychological burden to the entire cancer management plan.
has issue date	2020-06-14(xsd:dateTime)
bibo:doi	10.1007/s13304-020-00833-3
bibo:pmid	32537687
has license	no-cc
sha1sum (hex)	9eb633f8b4fa78eeaed05c1d39ce812b424cae6c
schema:url	https://doi.org/10.1007/s13304-020-00833-3
resource representing a document's title	Impact of COVID-19 on thyroid cancer surgery and adjunct therapy
has PubMed Central identifier	PMC7293828
has PubMed identifier	32537687
schema:publication	Updates Surg
resource representing a document's body	covid:9eb633f8b4fa78eeaed05c1d39ce812b424cae6c#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/9eb633f8b4fa78eeaed05c1d39ce812b424cae6c
is schema:about of	named entity 'Since' named entity 'modified' named entity 'rapid' named entity 'thyroidectomy' named entity 'patients' named entity 'surgery' named entity 'MANAGEMENT PLAN' named entity 'OPT' named entity 'DELIVERY' named entity 'DID' named entity 'SURGICAL' named entity 'plans' named entity 'thyroxine' named entity 'burden' named entity 'withdrawal method' named entity 'affect' named entity 'period' named entity 'plan' named entity 'neck dissection' named entity 'weeks' named entity 'All' named entity 'However' named entity 'neck dissection' named entity 'surgical procedures' named entity 'withdrawal method' named entity 'central compartment' named entity 'surgical care' named entity 'thyroid stimulating hormone' named entity 'TSH' named entity 'Thyroxine' named entity 'thyroid cancer' named entity 'COVID-19' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'thyroidectomy' named entity 'ablation' named entity 'ablation' named entity 'surgical care' named entity 'patient care' named entity 'COVID-19' named entity 'HAM-A' named entity 'herd immunity' named entity 'healthcare systems' named entity 'neck dissection' named entity 'thyroid stimulating hormone' named entity 'flu-like illness' named entity 'anxiety' named entity 'elective surgical' named entity 'central compartment' named entity 'THW' named entity 'surgical care' named entity 'ethical standards' named entity 'Surgical treatment' named entity 'adjunct therapy' named entity 'JOD' named entity 'Jordan' named entity 'viral transmission' named entity 'radioactive iodine' named entity 'thyroid cancer' named entity 'human participants' named entity 'adjunct therapy' named entity 'data analysis' named entity 'quarantine' named entity 'elective surgical' named entity 'thyroid cancer' named entity 'anxiety' named entity 'primum non nocere' named entity 'resource allocation' named entity 'anxiety' named entity 'medical care' named entity 'ablation' named entity 'mental health' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software